Search for key public statements, documents, or other formal exhibits submitted to the
U.S. Securities and Exchange Commission (SEC). Financial professionals and sophisticated
investors use these filings to find information on companies they are
evaluating for investment purposes.
Aradigm Corporation is rated below average in number of employees category among related companies. The total workforce of Drug Delivery industry is presently estimated at about 24,232. Aradigm adds roughly 11.0 in number of employees claiming only tiny portion of equities under Drug Delivery industry.
About 64.0% of the company shares are held by company insiders. The company recorded loss per share of 0.05. Aradigm Corporation last dividend was issued on March 1, 1996. Aradigm Corporationration, a specialty pharmaceutical company, engages in the development and commercialization of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists. The quote for Aradigm Corporation is listed on Over-The-Counter Bulletin Board (i.e. OTCBB), and the company does not need to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX echanges. For more info on ARADIGM CORP please contact Igor Gonda at 510-265-9000 or go to http://www.aradigm.com.
Aradigm Ownership Allocation (%)
Aradigm Profitability Analysis
The company reported revenue of 891 K. Net Loss for the year was (8.82 M) with profit before overhead, payroll, taxes, and interest of 791 K.
No recent SEC submissions found for this entity. Showing latest filings
Filed: 2012-05-25 AccNo: 0001165527-12-000548 Size: 15 MB
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
United States
Summary
Profile
Volatility
History
News
Chats
